Features of sorbilact-L-arginine-combined action on the kidneys' volumoregulatory function of patients with purulent-septic complications

<p><strong>The purpose</strong> of the work is to investigate the effect of combined use of sorbilact and L-arginine on the kidneys' volume-regulatory function of patients with endogenous intoxication syndrome (EIS) of purulent-septic origin in the period of stabilization of s...

Full description

Saved in:
Bibliographic Details
Main Authors: N. O. Maksymchuk (Author), V. M. Konovchuk (Author)
Format: Book
Published: Nicolaus Copernicus University in Toruń, Poland - University Sports Center, 2018-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_92fda6056e3d47caab5a663e5a4cfe12
042 |a dc 
100 1 0 |a N. O. Maksymchuk  |e author 
700 1 0 |a V. M. Konovchuk  |e author 
245 0 0 |a Features of sorbilact-L-arginine-combined action on the kidneys' volumoregulatory function of patients with purulent-septic complications 
260 |b Nicolaus Copernicus University in Toruń, Poland - University Sports Center,   |c 2018-01-01T00:00:00Z. 
500 |a 2450-6605 
500 |a 2450-6605 
500 |a 10.12775/PPS.2018.003 
520 |a <p><strong>The purpose</strong> of the work is to investigate the effect of combined use of sorbilact and L-arginine on the kidneys' volume-regulatory function of patients with endogenous intoxication syndrome (EIS) of purulent-septic origin in the period of stabilization of secondary toxic autoagression.</p><p><strong>Methods</strong>. Indicators of kidney volume receptor function have been studied in patients of the following groups. The first group (І, control) consisted of 31 patients with systemic inflammatory response syndrome (SIRS). The second group (ІІ) consisted of 22 patients with EIS who were treated according to Surviving Sepsis Campaign 2016 (standard therapy) [9]. The third group (ІІ) consisited of 24 patients with EIS, who received sorbilact in addition to standard therapy. The fourth group (IV) included 21 patients with SEI who received standard therapy as well as Sorbilact and L-arginine. Sorbilact infusion to patients of III and IV groups was performed at a rate of 6-7 ml/kg body weight, intravenously dripping at a rate of 7-8 ml/min. After the end of infusion of sorbilact, patients of IV group were infused with 4.2% solution of L-arginine ("Tivortin" intravenous drip according to the instructions). Data was obtained and results gathered on the application of drugs in the period of stabilization of secondary toxic autoagresion (fourth day of drugs' application).</p><p><strong>Findings. </strong>In the period of stabilization there is a restoration of the volume-regulatory function of the kidneys under standard therapy of endotoxicosis of purulent-septic genesis. The use of sorbilact with standard therapy activates the volume-regulatory function of the kidneys (in terms of sodium clearance by 31%, p <0,05) in the period of stabilization of toxic autoaggression. The combination of sorbilact with L-arginine increases the activity of sodium clearance by 12% (p <0,05) induced by sorbilact.</p><p><strong>Conclusions</strong><strong>. </strong>The investigated features of basic adjuvant therapy with L-arginine and sorbilact can be recommended for use in order to restore the volume-regulatory function of the kidneys in cases of endotoxicosis of purulent-septic genesis.</p> 
546 |a EN 
690 |a sorbilact 
690 |a l-arginine 
690 |a volumoregulatory function. 
690 |a Special aspects of education 
690 |a LC8-6691 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Psychology 
690 |a BF1-990 
655 7 |a article  |2 local 
786 0 |n Pedagogy and Psychology of Sport, Vol 4, Iss 1, Pp 31-36 (2018) 
787 0 |n https://apcz.umk.pl/czasopisma/index.php/PPS/article/view/16811 
787 0 |n https://doaj.org/toc/2450-6605 
787 0 |n https://doaj.org/toc/2450-6605 
856 4 1 |u https://doaj.org/article/92fda6056e3d47caab5a663e5a4cfe12  |z Connect to this object online.